MMWR Morb Mortal Wkly Rep. 2023 Aug 11;72(32):871-876. doi: 10.15585/mmwr.mm7232a4.
Persons receiving maintenance dialysis are at increased risk for SARS-CoV-2 infection and its severe outcomes, including death. However, rates of SARS-CoV-2 infection and COVID-19-related deaths in this population are not well described. Since November 2020, CDC's National Healthcare Safety Network (NHSN) has collected weekly data monitoring incidence of SARS-CoV-2 infections (defined as a positive SARS-CoV-2 test result) and COVID-19-related deaths (defined as the death of a patient who had not fully recovered from a SARS-CoV-2 infection) among maintenance dialysis patients. This analysis used NHSN dialysis facility COVID-19 data reported during June 30, 2021-September 27, 2022, to describe rates of SARS-CoV-2 infection and COVID-19-related death among maintenance dialysis patients. The overall infection rate was 30.47 per 10,000 patient-weeks (39.64 among unvaccinated patients and 27.24 among patients who had completed a primary COVID-19 vaccination series). The overall death rate was 1.74 per 10,000 patient-weeks. Implementing recommended infection control measures in dialysis facilities and ensuring patients and staff members are up to date with recommended COVID-19 vaccination is critical to limiting COVID-19-associated morbidity and mortality.
接受维持性透析的患者感染 SARS-CoV-2 及其严重后果（包括死亡）的风险增加。然而，该人群中 SARS-CoV-2 感染和与 COVID-19 相关的死亡的发生率尚未得到很好的描述。自 2020 年 11 月以来，CDC 的国家医疗保健安全网络（NHSN）每周收集数据，监测维持性透析患者中 SARS-CoV-2 感染（定义为 SARS-CoV-2 检测结果阳性）和与 COVID-19 相关的死亡（定义为 SARS-CoV-2 感染未完全康复的患者死亡）的发生率。本分析使用 NHSN 透析机构 COVID-19 数据，报告时间为 2021 年 6 月 30 日至 2022 年 9 月 27 日，描述维持性透析患者中 SARS-CoV-2 感染和与 COVID-19 相关的死亡的发生率。总体感染率为每 10000 个患者周 30.47 例（未接种疫苗患者为 39.64 例，完成 COVID-19 初级疫苗接种系列的患者为 27.24 例）。总体死亡率为每 10000 个患者周 1.74 例。在透析机构实施推荐的感染控制措施，并确保患者和工作人员及时接种推荐的 COVID-19 疫苗，对于限制 COVID-19 相关发病率和死亡率至关重要。
